Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutation With Advanced Breast Cancer Who Have Progressed on or After Prior Treatments
about
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutation With Advanced Breast Cancer Who Have Progressed on or After Prior Treatments
description
clinical trial
@en
klinisch onderzoek
@nl
name
Study Assessing the Efficacy a ...... d on or After Prior Treatments
@en
type
label
Study Assessing the Efficacy a ...... d on or After Prior Treatments
@en
prefLabel
Study Assessing the Efficacy a ...... d on or After Prior Treatments
@en
P17
P4844
P1476
BYLieve: A Phase II, Multicent ...... d on or After Prior Treatments
@en
P17
P1813
BYLieve
@en
P3098
NCT03056755
P580
2017-08-14T00:00:00Z
P582
2020-04-10T00:00:00Z